Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) is now available.
Aurobindo Pharma Limited announced changes in its senior management, with the resignation of Dr. Mandepudi Sudhakara Reddy, Associate President of Corporate QA, effective November 4, 2025, and the retirement of Mr. K. P. Ravinatha Shetty, President of Operations, on November 3, 2025. These changes mark a significant transition in the company’s leadership, potentially impacting its operational strategies and stakeholder relations.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Limited is a prominent player in the pharmaceutical industry, primarily engaged in the development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients. The company operates globally, focusing on providing affordable medication across various therapeutic areas.
Average Trading Volume: 65,255
Technical Sentiment Signal: Buy
Current Market Cap: 661.3B INR
See more insights into AUROPHARMA stock on TipRanks’ Stock Analysis page.